To pinpoint this new immunization strategy, scientists inhibited human cells from producing proteasomes in one group while ...

are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

An overview of potential applications of TLR1/2 agonists as vaccine adjuvant. This material relates to a paper that appeared in the April 10, 2015, issue of Science, published by AAAS. The paper ...

The human body's immune system is the primary defense against the dengue virus. When someone is infected with dengue, the body's innate and adaptive immune responses work together to fight the virus.